SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001123292-17-001401
Filing Date
2017-09-06
Accepted
2017-09-06 18:26:01
Documents
1
Period of Report
2017-09-01

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 5663
  Complete submission text file 0001123292-17-001401.txt   7225
Mailing Address 100 CUMMING CENTER SUITE 151-B BEVERLY MA 01915
Business Address 100 CUMMING CENTER SUITE 151-B BEVERLY MA 01915 978-921-4125
Innovation Pharmaceuticals Inc. (Issuer) CIK: 0001355250 (see all company filings)

IRS No.: 134303398 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 6475 CHRISTIE AVENUE SUITE 300 EMERYVILLE CA 94608
Business Address
Bertolino Arthur Peter (Reporting) CIK: 0001426344 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37357 | Film No.: 171072399